Stock APLLTD ALEMBIC PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Alembic Pharmaceuticals Limited

Equities

APLLTD

INE901L01018

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 12:43:53 28/06/2024 BST 		5-day change 1st Jan Change
876.6 INR -0.27% Intraday chart for Alembic Pharmaceuticals Limited +0.86% +15.43%
06-28 Alembic Pharmaceuticals Gets US FDA's Nod for Generic Inflammatory Skin Condition Drug MT
06-18 Alembic Pharmaceuticals Gets US FDA Nod for Dabigatran Etexilate Capsules MT

Business Summary

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API). It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology. Products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its India Formulations. Its subsidiaries include Alembic Pharmaceuticals Inc., Alembic Global Holding SA and others.

Number of employees: 14,858

Sales per Business

INR in Million2023Weight2024Weight Delta
Formulations
80.0 %
44,871 79.4 % 49,824 80.0 % +11.04%
Active Pharmaceutical Ingredients
20.0 %
11,655 20.6 % 12,462 20.0 % +6.92%

Sales per region

INR in Million2023Weight2024Weight Delta
International
60.1 %
33,390 59.1 % 37,448 60.1 % +12.15%
India
39.9 %
23,137 40.9 % 24,839 39.9 % +7.36%

Managers

Managers TitleAgeSince
Chirayu Ramanbhai Amin CEO
 Chief Executive Officer 76 30/04/83
Raj Kumar Shriram Baheti DFI
 Director of Finance/CFO 64 17/01/03
Manisha Saraf CMP
 Compliance Officer - 31/03/23
Pranav Chirayu Amin BRD
 Director/Board Member 48 31/12/06
Shaunak Chirayu Amin BRD
 Director/Board Member 46 30/03/11
Ajay Kumar Desai PRN
 Corporate Officer/Principal - 31/08/08

Members of the board

Members of the board TitleAgeSince
Chirayu Ramanbhai Amin CEO
 Chief Executive Officer 76 30/04/83
Raj Kumar Shriram Baheti DFI
 Director of Finance/CFO 64 17/01/03
Manish Santoshkumar Kejriwal BRD
 Director/Board Member 55 03-30
Archana Niranjan Hingorani BRD
 Director/Board Member 56 03/02/15
Shaunak Chirayu Amin BRD
 Director/Board Member 46 30/03/11
Ashok Kumar Barat BRD
 Director/Board Member 66 09/02/22
Pranav Chirayu Amin BRD
 Director/Board Member 48 31/12/06
Jai Shishir Diwanji BRD
 Director/Board Member 51 04/05/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 196,563,124 57,567,343 ( 29.29 %) 0 29.29 %

Shareholders

NameEquities%Valuation
Nirayu Pvt Ltd.
35.63 %
70,035,435 35.63 % 774 M ₹
ALEMBIC LIMITED
28.54 %
56,097,544 28.54 % 620 M ₹
Life Insurance Corporation of India (Investment Portfolio)
4.326 %
8,502,500 4.326 % 94 M ₹
DSP Asset Managers Pvt. Ltd.
4.037 %
7,934,399 4.037 % 88 M ₹
Chirayu Ramanbhai Amin
2.133 %
4,192,529 2.133 % 46 M ₹
Kotak Mahindra Asset Management Co. Ltd.
1.764 %
3,468,355 1.764 % 38 M ₹
Malika Chirayu Amin
1.529 %
3,005,730 1.529 % 33 M ₹
Axis Asset Management Co. Ltd.
0.7355 %
1,445,780 0.7355 % 16 M ₹
Government of India
0.7014 %
1,378,701 0.7014 % 15 M ₹
Pranav Chirayu Amin
0.5137 %
1,009,800 0.5137 % 11 M ₹

Company contact information

Alembic Pharmaceuticals Ltd.

Alembic Road

390003, Vadodara

+91 26 5663 7000

http://alembicpharmaceuticals.com
address Alembic Pharmaceuticals Limited(APLLTD)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Alembic Pharmaceuticals Limited

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
876.6 INR
Average target price
983.5 INR
Spread / Average Target
+12.20%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ALEMBIC PHARMACEUTICALS LIMITED Stock Alembic Pharmaceuticals Limited
+15.43% 2.07B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.32% 819B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.75% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+13.56% 329B
ABBVIE INC. Stock AbbVie Inc.
+10.68% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.57% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+2.04% 225B
NOVARTIS AG Stock Novartis AG
+13.31% 217B
AMGEN INC. Stock Amgen Inc.
+8.48% 168B
PFIZER, INC. Stock Pfizer, Inc.
-2.81% 158B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. APLLTD Stock
  4. Company Alembic Pharmaceuticals Limited